What does TScan Therapeutics, Inc. (TCRX) do?

TScan Therapeutics, Inc. (TCRX) is a publicly traded company in the Healthcare sector.

What sector does TCRX operate in?

TScan Therapeutics, Inc. operates in the Healthcare, specifically within the Biotech industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find TCRX earnings analysis?

AlphaOS publishes an earnings intelligence page for TScan Therapeutics, Inc. (TCRX) covering results, guidance context, and AI-assisted analysis. See /stocks/TCRX/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

TCRX

TScan Therapeutics, Inc.

Healthcare · Biotech

$0.32Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

TScan Therapeutics, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -66% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -66% YoY in Q2 FY2026

Pipeline evidence · 0d ago

TCRX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TCRX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full TCRX earnings analysis

Reported figures for TScan Therapeutics, Inc. — research only, not investment advice.

Revenue YoY: -65.9%

Latest Intelligence

Updated September 30, 2026

What happened recently for TScan Therapeutics, Inc. (TCRX) — events, not interpretation.

Event: Reported Q2 2026 revenue -66% YoY.
Also: Last session September 29, 2026 at $0.32.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

TScan Therapeutics, Inc. (TCRX)

Healthcare · Biotech

Investment Snapshot above is the primary AlphaOS analysis for TScan Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotech
Market cap:: $7.61M
Revenue:: $982,000

TCRX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow TScan Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Biological Products, (No Diagnostic Substances)90% confidencerelated

Connected companies and research pages from the AlphaOS knowledge graph.